PAVmed (PAVM) Capital Expenditures (QoQ) (2016 - 2025)
PAVmed (PAVM) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | PAVmed | 32.44 Mn | 28.66 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 366.67% |
| Sep 30, 2025 | -62.50% |
| Jun 30, 2025 | 33.33% |
| Mar 31, 2025 | 50.00% |
| Jun 30, 2024 | -92.86% |
| Mar 31, 2024 | -77.05% |
| Dec 31, 2023 | 916.67% |
| Sep 30, 2023 | 20.00% |
| Jun 30, 2023 | -42.31% |
| Mar 31, 2023 | -91.28% |
| Dec 31, 2022 | -5.70% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -38.68% |
| Mar 31, 2022 | -55.05% |
| Dec 31, 2021 | 3,548.57% |
| Sep 30, 2021 | -71.07% |
| Jun 30, 2021 | 236.11% |
| Mar 31, 2021 | 350.00% |
| Dec 31, 2020 | 166.67% |
| Sep 30, 2020 | -92.86% |